Image credit: AP Photo/Kathy Young

In a First, a Cannabis-Derived Pharma Product Is Descheduled in the US

The DEA has taken Epidiolex, a CBD-based formula for rare forms of epilepsy, completely off its list of controlled substances. Why? The 2018 Farm Bill.

CBD
Research

A First: National Institutes of Health Issues RFI on Cannabis Research Barriers

The request for information is NIH’s first on these barriers, and it includes eight participants, from the National Cancer Institute to the National Institute on Aging.

Business

Marlboro-Maker Altria Tinkers With Cannabis Flavors

In new patent applications, Altria and the University of Virginia focus on how to modify cannabis plants to “control the formation of terpenes that impart specific flavor and aroma characteristics.”

Colombia

Colombia: A New President Could Jump-Start Cannabis 

The industry will be seen as a player in the economy—and likely legalized—after President-elect Gustavo Petro takes office on August 7.